1-1 of 1
Eric Guemas
Close
Sort by
Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Clinical Trials & Observations
Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant
Journal: Blood Advances
Blood Adv (2019) 3 (2): 184–186.
https://doi.org/10.1182/bloodadvances.2018028282
Published: 2019